Lab Reference Library / Heavy Metals Panel (Mercury, Lead, Arsenic, Cadmium) Detox, Mold & CIRS

Heavy Metals Panel (Mercury, Lead, Arsenic, Cadmium)

Heavy Metals · Toxic Element Panel · Mercury Lead Arsenic Cadmium

Reference ranges, optimal functional medicine levels, and why each major toxic metal has a distinct exposure source, target organ, specimen type, and elimination strategy, how methylmercury from fish produces peripheral neuropathy and cognitive decline, and why speciated arsenic must be ordered separately from total arsenic to avoid false interpretation.

Environmental ToxinMulti-Metal Panel

MercuryBelow 5 mcg/L blood

LeadBelow 5 mcg/dL blood

ArsenicSpeciated inorganic

CadmiumBelow 0.5 mcg/L blood

← Back to Lab Reference Library

Category: Detox, Mold & CIRS | Also known as: Mercury Lead Arsenic Cadmium, Toxic Element Panel, Blood Urine Metal Testing

1. What This Test Measures

Heavy metals panels measure the blood, urine, or hair concentration of potentially toxic elements that accumulate in human tissues and produce dose-dependent organ-specific toxicity. The term "heavy metals" is clinically imprecise but conventionally refers to elements with high atomic weights that lack known biological function at any concentration (mercury, lead, cadmium, arsenic, thallium, barium) or elements that are nutritionally essential at low concentrations but toxic in excess (copper, zinc, manganese, chromium, selenium, molybdenum). Clinical panels typically focus on the four elements with the most common and significant toxicity in the general population: mercury, lead, arsenic, and cadmium, with aluminum, nickel, cobalt, barium, and thallium added depending on occupational or residential exposure history.

Each toxic metal has a distinct exposure source profile, target organ specificity, biological half-life, and appropriate specimen type for testing. Mercury is primarily a neurotoxin from methylmercury in seafood and inorganic mercury from dental amalgam; its half-life in blood is approximately 70 days but it accumulates in brain, kidney, and liver tissue for years. Lead is a multi-organ toxin affecting the nervous system (particularly neurodevelopment in children), kidneys, cardiovascular system, and reproductive organs; it has a blood half-life of approximately 28 days but accumulates in bone for decades. Arsenic is primarily a carcinogen and peripheral neuropathy toxin from contaminated well water and rice; it has a blood half-life of 2 to 4 days (for inorganic forms) but long-term accumulation in keratin-containing tissues (hair, nails). Cadmium is primarily a nephrotoxin that accumulates irreversibly in the kidney cortex with a biological half-life of 10 to 30 years; even after exposure cessation, cadmium-induced kidney damage may continue to progress.

Specimen selection is critical for meaningful heavy metals interpretation. Blood levels reflect recent or ongoing exposure (past 30 to 90 days for most metals) and are appropriate for identifying current exposure sources and acute poisoning. Urine levels reflect ongoing renal excretion of circulating metals and, for some metals (arsenic, cadmium, nickel), provide better sensitivity for chronic low-level exposure than blood. Hair analysis reflects the incorporation of metals into growing hair over the preceding months, providing a historical exposure timeline, but suffers from significant contamination risks and methodological variability that limits clinical reliability without rigorous specimen preparation.

2. Reference Ranges by Metal

Metal	Optimal Specimen	Reference (Action) Threshold	Primary Concern
Mercury (total)	Whole blood	Below 5 mcg/L; FM optimal below 3	Neurotoxicity, nephrotoxicity; fish, amalgam
Mercury (methylmercury)	Whole blood	Below 3.5 mcg/L	Neurotoxin; large predatory fish
Lead	Whole blood	Below 5 mcg/dL adults; below 3.5 children	No safe level; neurodevelopmental, CV, renal
Arsenic (inorganic speciated)	24-hr urine or spot	Below 35 mcg/L (speciated inorganic only)	Carcinogen; peripheral neuropathy
Cadmium	Blood or urine	Below 0.5 mcg/L blood; below 1.0 mcg/g Cr urine	Nephrotoxin; tobacco, diet
Aluminum	Serum (no gel tubes)	Below 10 mcg/L	Neurotoxicity in renal failure; dialysis

For arsenic: always order speciated arsenic, never total arsenic alone. Organic arsenobetaine from seafood consumption is non-toxic and dramatically elevates total arsenic without clinical significance. Speciated testing identifies inorganic arsenic (toxic) separately from organic arsenicals. For mercury: whole blood mercury measures both methylmercury (red blood cell-associated, from fish) and inorganic mercury (plasma-associated, from amalgam and industrial exposure). Request fractionated mercury for more precise source attribution.

3. Mercury: The Most Common Clinical Heavy Metal Concern

Sources and Exposure Assessment

Methylmercury from seafood: the dominant mercury exposure route for most non-occupationally exposed adults; methylmercury bioaccumulates in marine food chains, reaching highest concentrations in long-lived predatory fish: king mackerel (mean 0.73 ppm), swordfish (0.97 ppm), shark (0.98 ppm), tilefish (from Gulf of Mexico, 1.12 ppm), and bigeye tuna (0.68 ppm); frequent consumption of these species drives blood mercury above 5 mcg/L in many patients without awareness
Lower-mercury seafood alternatives: salmon (wild: 0.014 ppm), sardines (0.013 ppm), herring (0.084 ppm), anchovies (0.017 ppm), Atlantic mackerel (not king mackerel, 0.050 ppm), and farmed oysters and clams; these provide the omega-3 benefits of seafood consumption with dramatically lower methylmercury burden; light canned tuna (0.128 ppm) is acceptable in moderation but not daily
Dental amalgam: mercury vapor is continuously released from amalgam fillings, particularly during chewing, teeth grinding, and hot food and beverage consumption; the contribution to blood mercury is typically lower than seafood exposure but may be significant in patients with many large amalgams; inorganic mercury from amalgam distributes differently from methylmercury and requires urine mercury testing for full characterization
Occupational exposure: dental professionals, fluorescent lamp manufacturers, mining workers, and certain laboratory and industrial workers face inorganic mercury exposure; occupational mercury exposure is typically much higher than dietary and requires biological monitoring in workplace health programs

Clinical Manifestations of Mercury Toxicity

Neurological: the primary target system for methylmercury; symptoms include intentional tremor (characteristic fine tremor that worsens with purposeful movement), cognitive decline (memory, concentration, processing speed), peripheral paresthesias and neuropathy (numbness and tingling in hands and feet), ataxia, visual field constriction (concentric narrowing), hearing loss, and emotional lability; the clinical picture of mercury neurotoxicity is often misattributed to essential tremor, early dementia, anxiety disorder, or idiopathic peripheral neuropathy
Renal: mercury accumulates in proximal renal tubular cells, producing tubular dysfunction; early findings include microalbuminuria, elevated urinary beta-2 microglobulin, and increased urinary N-acetyl glucosaminidase; severe exposure can produce nephrotic syndrome from mercury-induced immune complex glomerulonephritis
Autoimmune: mercury is a potent immune sensitizer; it induces T cell activation and autoantibody production; mercury exposure is associated with antinuclear antibody development, antiglomerular basement membrane antibody induction, and aggravation of pre-existing autoimmune conditions; patients with unexplained new positive ANA or worsening autoimmune disease should have mercury checked
Cardiovascular: high blood mercury is associated with increased cardiovascular disease risk through endothelial dysfunction, oxidative stress, and interference with selenium-dependent antioxidant enzymes; the association is particularly pronounced for fish-derived methylmercury counteracting the cardiovascular benefits of fish omega-3 consumption

4. Lead, Arsenic, and Cadmium: Key Clinical Considerations

Lead: there is no known safe blood lead level, particularly for children where cognitive and behavioral effects occur at levels previously considered acceptable; in adults, blood lead above 5 mcg/dL is associated with hypertension, chronic kidney disease, peripheral neuropathy, and impaired cognitive function; common adult exposure sources include older homes with lead paint and plumbing (pre-1978 construction), imported ceramic dishware with lead glazes, some imported spices (particularly turmeric, paprika, and chili powder), traditional herbal remedies from Asia and Latin America, and occupational exposure in construction, firing ranges, battery recycling, and auto repair; bone lead stores accumulated over a lifetime are released back into the bloodstream during pregnancy and osteoporosis, making historical lead exposure an ongoing concern even after current exposure elimination
Arsenic: the most important clinical point is specimen selection and speciation; total urine arsenic is nearly always elevated in seafood consumers because the abundant arsenobetaine in shellfish and seaweed is non-toxic but dominates total arsenic measurement; inorganic arsenic (the toxic fraction from contaminated water and rice) must be specifically measured; private well water testing for arsenic is essential in patients from agricultural or mining regions; rice contains arsenic bioconcentrated from soil and water, and rice-based products (rice cakes, rice cereal, rice flour) are dietary arsenic sources that may be significant for patients consuming rice as a primary grain; breast cancer, bladder cancer, and skin cancer risk are the most robustly associated with chronic inorganic arsenic exposure; peripheral neuropathy, Mees' lines (transverse white lines on nails), and skin hyperpigmentation and hyperkeratosis are clinical signs of chronic arsenic poisoning
Cadmium: tobacco smoke is by far the primary cadmium source for smokers (cigarette cadmium content 1 to 2 mcg per cigarette with approximately 10 to 40% lung absorption); non-smokers are primarily exposed through dietary sources (shellfish, organ meats, leafy vegetables grown in cadmium-rich soil, and grains); cadmium's 10 to 30 year biological half-life in the kidney cortex means that exposure that occurred decades ago continues to be excreted in urine and continues to damage renal tubular cells; urine cadmium (adjusted for creatinine) is the best measure of cumulative kidney cadmium burden; early cadmium nephrotoxicity presents as increased urinary beta-2 microglobulin and metallothionein before serum creatinine rises; osteoporosis and bone pain (Itai-itai disease in severe cadmium poisoning) result from cadmium-induced renal phosphate wasting and vitamin D metabolism disruption

5. Blood vs Urine vs Provocation: Choosing the Right Test

Specimen type selection is the most important decision in heavy metals evaluation because different specimens provide fundamentally different information, and misinterpretation of the appropriate specimen for the clinical question leads to both false reassurance and inappropriate alarm.

Blood heavy metals reflect recent or ongoing exposure and are appropriate for: identifying current exposure sources, diagnosing acute or subacute poisoning, monitoring compliance with exposure reduction interventions, and baseline occupational health screening. Blood levels fall as exposure ceases and the metal redistributes to tissues; a patient who stopped eating high-mercury fish 3 months ago will have a normal blood mercury despite potentially significant tissue burden. Urine heavy metals reflect renal excretion of metals currently being eliminated from the body; urine is the preferred specimen for arsenic (total and speciated), cadmium (as a cumulative kidney burden marker), and nickel; urine mercury reflects inorganic mercury excretion from the kidneys and is complementary to blood mercury for characterizing amalgam-related exposure. Hair analysis provides a historical timeline of exposure but is subject to external contamination and requires specialized preparation and interpretation; it is not recommended by mainstream toxicological societies as a primary clinical diagnostic tool but may provide adjunctive exposure timeline information when proper protocols are followed. Provocative chelation challenge testing (measuring urine metals after administration of a chelating agent) is not recommended by the American College of Medical Toxicology, ACMT, or mainstream toxicology guidelines for routine body burden assessment; it produces falsely elevated results that do not correlate with tissue body burden and has led to inappropriate chelation therapy with significant adverse effects.

6. How to Reduce Heavy Metal Exposure and Support Elimination

Exposure Reduction (Primary)

Dietary mercury reduction: eliminate or strictly limit swordfish, king mackerel, tilefish, shark, and bigeye tuna; substitute salmon, sardines, herring, anchovies, and oysters; limit light canned tuna to 2 to 3 servings weekly; these changes alone will normalize blood mercury in most fish-consuming patients within 2 to 3 months
Lead source identification and removal: test home for lead paint if built before 1978 (EPA RRP rule requires professional testing before renovation); test tap water if home has lead pipes or lead solder (pre-1986 plumbing); use cold water filtered through NSF-certified lead-removal filters for drinking and cooking; test imported ceramics and antique dishware before use
Smoking cessation for cadmium: the most impactful single intervention for cadmium reduction; each year of smoking cessation reduces subsequent cadmium accumulation; existing kidney cadmium burden cannot be meaningfully removed but further accumulation is prevented
Organic and filtered diet for arsenic: organic rice and rice products; consider alternative grains (quinoa, millet, buckwheat) as primary grain sources; test private well water; avoid herbal supplements from regions with high soil arsenic

Nutritional Support for Elimination

Glutathione optimization (NAC 600mg twice daily, or liposomal glutathione 500mg daily): mercury, arsenic, and cadmium are all eliminated through glutathione conjugation in the liver; glutathione-S-transferase enzymes conjugate these metals for biliary and urinary excretion; NAC provides the rate-limiting cysteine precursor for glutathione synthesis and is one of the most evidence-based nutritional supports for heavy metal elimination
Selenium (100 to 200mcg daily as selenomethionine): forms an equimolar complex with methylmercury (MeHg-Se complex) that sequesters mercury in a biologically inert form, reducing its access to nervous system targets; selenium sufficiency is protective against mercury neurotoxicity; the fish-selenium co-provision in many marine species partially explains why the omega-3 benefits of fish consumption often outweigh the mercury risk in populations with adequate selenium status
Alpha-lipoic acid (600mg daily): water and fat-soluble antioxidant that crosses the blood-brain barrier and reduces mercury-driven oxidative stress in CNS tissue; also supports glutathione recycling by reducing oxidized glutathione back to its active form
Chlorella (3 to 5g daily): fresh water algae with documented mercury and lead binding capacity in the gut; reduces reabsorption of metals entering the enterohepatic circulation; evidence for urinary mercury reduction with consistent chlorella supplementation in several small human studies
Modified citrus pectin (5g three times daily): soluble fiber from citrus peel that has demonstrated heavy metal binding in the gut and promotion of urinary metal excretion in clinical studies; palatable and well-tolerated; evidence for cadmium, lead, and arsenic urinary excretion enhancement

Adjunctive Therapies

Sauna therapy (infrared or traditional): sweat contains detectable concentrations of mercury, cadmium, lead, and arsenic; regular sauna use (3 to 4 sessions weekly, 20 to 30 minutes at moderate temperature) promotes sweat-based metal elimination as an adjunctive pathway to urinary excretion; ensure adequate electrolyte replacement (sodium, potassium, magnesium) and hydration after each session to prevent depletion
Medical chelation therapy (DMSA, DMPS, EDTA): FDA-approved chelating agents are indicated for confirmed heavy metal poisoning at clinically significant levels: DMSA (succimer) for lead, mercury, and arsenic; DMPS (dimercaptopropane sulfonate) for mercury and arsenic (investigational in US, available in Europe); EDTA for lead (IV formulation) and calcium disodium EDTA for adjunctive use; medical chelation carries significant risks including essential mineral depletion, renal stress, and redistribution of metals from bone and tissue to the bloodstream and must be supervised by a physician experienced in toxicological chelation
Adequate calcium and iron for lead protection: calcium and iron compete with lead for intestinal absorption through shared divalent metal transporters (DMT1); adequate dietary calcium (1,000 to 1,200mg daily) and iron (correcting deficiency) provide competitive protection against lead absorption, particularly important in children and pregnant women; calcium supplementation during pregnancy reduces maternal lead mobilization from bone stores
Vitamin C (1,000 to 2,000mg daily): reduces the toxicity of several heavy metals through antioxidant mechanisms; vitamin C combined with chelation therapy reduces oxidative DNA damage from metal-induced reactive oxygen species; also supports connective tissue repair in patients with lead-related collagen disruption

7. Related Lab Tests

PhthalatesEndocrine-Disrupting Plasticizer Companion Environmental Assessment

→

GlyphosateHerbicide Exposure Companion Environmental Assessment

→

Mycotoxin PanelMold Toxin Companion in Comprehensive Environmental Medicine Evaluation

→

FerritinLead Competes with Iron; Assess Iron Status Alongside Lead Testing

→

eGFRCadmium and Lead Are Both Nephrotoxic; Monitor Kidney Function

→

HomocysteineMercury Inhibits Methionine Synthase and CBS; Elevates Homocysteine

→

8. Clinical Perspective

Clinical Perspective

Heavy metal testing gives me answers in patients who have been sick for years without an explanation, because it is one of the areas where a single laboratory result can convert a mystery into a mechanism. The patient who has eaten swordfish or tuna four to five times per week for a decade and has progressive peripheral neuropathy, intention tremor, cognitive slowing, and emotional lability, with whole blood mercury of 34 mcg/L, has an explanation for an illness that multiple neurologists attributed to anxiety, essential tremor, or early Parkinson's. Mercury neuropathy and mercury-induced cognitive impairment are real, measurable through a simple blood draw, and in many cases reversible with dietary modification and nutritional support for glutathione-mediated mercury elimination. The conversation I have with that patient after showing them their mercury level, explaining which specific fish are driving the exposure, and creating a concrete dietary change plan with a follow-up test at 90 days is the beginning of a meaningful therapeutic relationship rather than another frustrating referral. The same is true for the patient with a blood lead of 18 mcg/dL from decades of living in a pre-1978 home with damaged lead paint, or the agricultural worker with a cadmium level reflecting 30 years of tobacco use. These are not obscure findings; they are common, identifiable, and addressable if we look for them.

Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma

9. Frequently Asked Questions

Which heavy metals should be tested and in what specimen?

Standard functional medicine screening includes whole blood mercury, whole blood lead, speciated urine arsenic (not total), and blood or urine cadmium. Always order speciated arsenic, not total arsenic, to distinguish the toxic inorganic fraction from non-toxic organic arsenobetaine from seafood. Mercury fractionation (methyl vs inorganic) provides source attribution. The specimen choice matters: blood for recent/ongoing exposure (mercury, lead), urine for arsenic (speciated) and cadmium, hair for historical timeline supplemental information only.

Is blood mercury above 5 mcg/L dangerous?

Blood mercury above 5 mcg/L is above the CDC reference value indicating exposure greater than 95% of the US population, but clinical symptoms of mercury neurotoxicity typically emerge at levels of 10 to 20+ mcg/L with chronic exposure. Levels of 5 to 10 mcg/L warrant dietary seafood modification and monitoring; levels above 10 mcg/L warrant aggressive dietary change, nutritional support for mercury elimination, and clinical evaluation for subtle neurotoxicity signs; levels above 20 mcg/L warrant specialist evaluation and may indicate consideration of chelation therapy if neurological symptoms are present.

Why should provocative chelation challenge testing be avoided for body burden assessment?

Provocative chelation challenge testing (measuring urine metals after oral or IV chelating agent administration) produces artificially elevated urine metal levels that do not correlate with actual body burden or clinical toxicity. The American College of Medical Toxicology, ACMT, and mainstream toxicological guidelines explicitly discourage provocation testing because: it produces false-positive results that lead to inappropriate chelation of patients without genuine toxicity; the "reference ranges" used for provocation test interpretation are based on other challenged specimens, not normal physiological excretion; and chelation therapy carries significant risks including essential mineral depletion, renal stress, and redistribution of bone-stored metals to the bloodstream.

Can heavy metals be removed without prescription chelation drugs?

For most patients with levels in the range found in functional medicine practice (subclinical elevation rather than frank poisoning), nutritional and dietary approaches can produce meaningful heavy metal reduction without prescription chelating agents. Dietary modification (eliminating high-mercury fish, lead source identification and removal, smoking cessation for cadmium) is the foundation. Glutathione support with NAC, selenium for mercury, modified citrus pectin, chlorella, and sauna therapy provide adjunctive elimination support. These approaches produce gradual, sustained reduction over weeks to months without the risks of aggressive chelation. Prescription chelation (DMSA, EDTA) is appropriate for confirmed poisoning at clinically significant levels under specialist supervision.

How do I know if my symptoms are from heavy metal toxicity?

Heavy metal toxicity should be considered when: unexplained neurological symptoms (tremor, peripheral neuropathy, cognitive decline, emotional changes) are present without other explanation; exposure history is consistent (frequent predatory fish consumption, older home construction, tobacco use, industrial exposure); conventional neurological evaluation is unrevealing; and symptoms have a gradual progressive onset over months to years. Standard blood and urine heavy metals testing establishes the diagnosis. Improvement in symptoms following documented metal level reduction through dietary change and nutritional support provides the most compelling evidence of causation.

Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.

Heavy metal toxicity is identifiable from a blood draw, attributable to specific exposure sources, and in many cases reversible with systematic exposure reduction and nutritional elimination support.

Heavy metal assessment is an essential component of unexplained neurological and chronic illness evaluation. Schedule a consultation for a comprehensive environmental toxin and heavy metal panel with personalized reduction and elimination planning.

Schedule a Consultation

Medical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.